Increased aspartate aminotransferase activity in cerebrospinal fluid and Alzheimer's disease

Lancet

Volumn 352, Issue 9124, 1998, Pages 287-

  Tapiola, T ^a   Lehtovirta, M ^a   Pirttila T ^a   Alafuzoff, I ^a   Riekkinen, P ^a   Soininen, H ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 0032566190     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)60260-7     Document Type: Article

References (5)

1. 42 in the cerebrospinal fluid of patients with Alzheimer's disease. Ann Neurol 1995; 38: 643-48.
2. 2 Trojanowski JQ, Clark CM, Aria H, Lee VM. Elevated levels of tau in cerebrospinal fluid: implications for the antemortem diagnosis of Alzheimer's disease. Alzheimer Dis Rev 1996; 1: 77-83.
3. 3 Riemenschneider M, Buch K, Schmolke M, Kurz A, Guder WG. Diagnosis of Alzheimer's disease with cerebrospinal fluid tau protein and aspartate aminotransferase. Lancet 1997; 350: 784.
4. 4 Esmonde T. Diagnosis of Alzheimer's disease with cerebrospinal fluid tau protein and aspartate aminotransferase. Lancet 1998; 351: 63-64.
5. 5 Maas AIR. Cerebrospinal fluid enzymes in acute brain injury, 2: relation of CSF enzyme activity to extent of brain injury. J Neurol Neurosurg Psychiatry 1977; 40: 666-74.